Rosnilimab

N/A

Report date: 2024/07/04 16:27:37

Base Information

Drug NameRosnilimab
Drug Alias NameANB-030
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionProgrammed cell death protein 1 agonists
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsAlopecia AreataColitis, UlcerativeArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[21] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnaptysbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnaptysbio Inc
Inactive CompaniesN/A
Active IndicationsColitis, UlcerativeArthritis, Rheumatoid
Inactive IndicationsAlopecia Areata

Other Information

ATC CodeN/A
Related LinksN/A